ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Protocol Allograft Kidney Biopsy in DeNovo Donor Specific Antibodies.

S. Parajuli, P. Reville, T. Ellis, A. Djamali, D. Mandelbrot.

University of Wisconsin, Madison, WI

Meeting: 2017 American Transplant Congress

Abstract number: 50

Keywords: Biopsy, Kidney transplantation

Session Information

Session Name: Concurrent Session: Kidney HLA Antibodies

Session Type: Concurrent Session

Date: Sunday, April 30, 2017

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:06pm-3:18pm

Location: E354b

There is limited information about the role of protocol kidney biopsies for de-novo donor specific antibodies (dnDSA) in kidney transplant recipients (KTR). We initiated monitoring of DSA per consensus conference recommendations during the first year post transplant and then annually, and performed a surveillance biopsy for dnDSA. There were 47 kidney transplant recipients with dnDSA between 01/1/2014 and 06/30/2016. Median age at time of transplant was 48±12 years, 68% were male. The most common causes of end stage renal disease were diabetes and glomerulonephritis. 38% were living kidney recipients and 17% were re-transplants. More than 60% received basilixmab for the induction. 42 patients underwent biopsy within 60 days of development of dnDSA while 5 did not. On biopsy, 26 (63%) had rejection and 16 (37%) did not. There were no significant differences in baseline demographics between rejection and no-rejection groups. Comparing no rejection vs rejection groups, 56% vs 12% had class I dnDSA (p=0.002), 31% vs 46% (p=0.35) had class II and 13% vs 42% (p=0.04) had both class I & II dnDSA. There were no significant differences in mean florescent intensity (MFIsum) between the two groups. Median post-transplant follow-up was 795 days in the no-rejection group and 921 days in the rejection group. Of those with rejection, 35% had cellular rejection (ACR), 35% had antibody-mediated rejection (AMR) and 30% had mixed rejection.Of the 42 patients who underwent biopsy, 22 had serum creatinine (Scr) and urine protein level at their baseline. Out of those 22 patients, 10 (45%) had sub clinical rejection. There was one graft loss in the no-rejection group and three in rejection group (p=0.83). Our findings demonstrate the utility of protocol biopsies in KTR with dnDSA. We found a high rate of rejection (62%) and clinically silent rejection (45%). In addition, biopsy findings were relatively evenly divided between ACR, AMR and mixed rejection, which require different treatments.

CITATION INFORMATION: Parajuli S, Reville P, Ellis T, Djamali A, Mandelbrot D. Outcomes of Protocol Allograft Kidney Biopsy in DeNovo Donor Specific Antibodies. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Parajuli S, Reville P, Ellis T, Djamali A, Mandelbrot D. Outcomes of Protocol Allograft Kidney Biopsy in DeNovo Donor Specific Antibodies. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-protocol-allograft-kidney-biopsy-in-denovo-donor-specific-antibodies/. Accessed May 9, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences